false
0001808377
0001808377
2025-11-04
2025-11-04
0001808377
lucy:CommonStockParValue0.00001PerShareMember
2025-11-04
2025-11-04
0001808377
lucy:WarrantsToPurchaseCommonStockMember
2025-11-04
2025-11-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2025
INNOVATIVE EYEWEAR, INC.
(Exact name of registrant as specified in its charter)
| Florida |
|
001-41392 |
|
85-0734861 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
11900 Biscayne Blvd., Suite 630
North Miami, Florida |
|
33181 |
| (Address of principal executive offices) |
|
(Zip Code) |
(786)
785-5178
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.00001 per share |
|
LUCY |
|
The Nasdaq Stock Market LLC |
| Warrants to purchase Common Stock |
|
LUCYW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
5.02. Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 4, 2025, Konrad Dabrowski resigned
as the Co-Chief Financial Officer of Innovative Eyewear, Inc. (the “Company”) and agreed to a change in title to Chief AI
and Growth Officer of the Company. Oswald Gayle, who has served as the Company’s Co-Chief Financial Officer alongside Mr. Dabrowski,
will now hold the title of Chief Financial Officer and serve as the Company’s principal financial officer. No changes to Mr. Dabrowski
or Mr. Gayle’s compensation were made in connection with the change in their titles and responsibilities.
The Board of Directors approved the change of
titles for Mr. Dabrowski and Mr. Gayle, effective November 1, 2025.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 7, 2025
| |
By: |
/s/ Harrison Gross |
| |
Name: |
Harrison Gross |
| |
Title: |
Chief Executive Officer |